Sapiens International (SPNS)

• Market cap: $1.45B
• 1 day: -0.15%
• 5 days: 1.29%
• 1 month: -6.95%
• 3 months: 1.84%
• 6 months: -28.56%
• Year to date: -0.38%
• 1 year: -14.08%
• 5 years: 23.59%
• 10 years: 210.89%
• Sector: Technology
• Industry: Software - Application

About: Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.

Employees: 4,850

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

1,636% more call options, than puts

Call options by funds: $191K | Put options by funds: $11K

100% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 2 (+1) [Q4]

1.99% more ownership

Funds ownership: 34.86% [Q3] → 36.85% (+1.99%) [Q4]

5% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 22

2% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 57

0% more funds holding

Funds holding: 168 [Q3] → 168 (+0) [Q4]

24% less capital invested

Capital invested by funds: $724M [Q3] → $552M (-$172M) [Q4]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $28 8% upside
• Avg. target: $30 17% upside
• High target: $35 35% upside

3 analyst ratings

• positive: 1 33%
• neutral: 1 33%
• negative: 1 33%

Needham Mayank Tandon 32% 1-year accuracy 37 / 114 met price target	35% upside $35	Buy Reiterated	19 Feb 2025
Barclays Tavy Rosner 42% 1-year accuracy 5 / 12 met price target	8% upside $28	Underweight Maintained	19 Feb 2025
Jefferies Surinder Thind 24% 1-year accuracy 5 / 21 met price target	8% upside $28	Hold Downgraded	3 Feb 2025